• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    'Independence Realty Trust Set to Join S&P MidCap 400; Alpha and Omega Semiconductor & Dynavax Technologies to Join S&P SmallCap 600' -S&P Dow Jones Indices

    5/12/22 5:19:32 PM ET
    $AOSL
    $DVAX
    $EPAY
    $IRT
    Semiconductors
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AOSL alert in real time by email

    https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20220512-1452376/1452376_mime4epay6.pdf

    Get the next $AOSL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AOSL
    $DVAX
    $EPAY
    $IRT

    CompanyDatePrice TargetRatingAnalyst
    Independence Realty Trust Inc.
    $IRT
    1/20/2026$18.00Buy → Hold
    Deutsche Bank
    Independence Realty Trust Inc.
    $IRT
    1/9/2026$22.00Market Perform → Outperform
    BMO Capital Markets
    Independence Realty Trust Inc.
    $IRT
    12/4/2025$18.50Buy → Neutral
    Colliers Securities
    Alpha and Omega Semiconductor Limited
    $AOSL
    11/6/2025$24.00Buy → Neutral
    B. Riley Securities
    Independence Realty Trust Inc.
    $IRT
    8/1/2025$24.00Neutral → Buy
    Compass Point
    Alpha and Omega Semiconductor Limited
    $AOSL
    7/15/2025$25.00Sell → Hold
    Stifel
    Independence Realty Trust Inc.
    $IRT
    5/13/2025$22.00Buy → Neutral
    Compass Point
    Independence Realty Trust Inc.
    $IRT
    4/7/2025$24.00Buy
    UBS
    More analyst ratings

    $AOSL
    $DVAX
    $EPAY
    $IRT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Independence Realty Trust Announces Fourth Quarter and Full Year 2025 Financial Results

    Independence Realty Trust, Inc. ("IRT") (NYSE:IRT), a multifamily apartment REIT, announces its fourth quarter and full year 2025 financial results. EPS of $0.24 for Full Year 2025 CFFO Per Share of $0.32 for Fourth Quarter and $1.17 for Full Year 2025 In Line with Expectations Same-Store Portfolio NOI Growth of 1.8% and 2.4% for the Fourth Quarter and Full Year 2025 Driven by 2.0% and 1.7% Same-Store Revenue Growth in the Fourth Quarter and Full Year 95.6% Same Store Portfolio Occupancy at End of Fourth Quarter 95.4% Average Occupancy for the Full Year, a 30 Basis Point Increase Over 2024 61.4% Resident Retention Rate in Fourth Quarter and 59.8% for the Full Year 2025 Completed

    2/11/26 4:05:00 PM ET
    $IRT
    Real Estate Investment Trusts
    Real Estate

    Alpha and Omega Semiconductor Reports Financial Results for the Fiscal Second Quarter of 2026 Ended December 31, 2025

    Alpha and Omega Semiconductor Limited ("AOS") (NASDAQ:AOSL) today reported financial results for the fiscal second quarter of 2026 ended December 31, 2025. The results for the fiscal second quarter of 2026 ended December 31, 2025 were as follows: GAAP Financial Comparison Quarterly (in millions, except percentage and per share data) (unaudited)     Three Months Ended     December 31, 2025   September 30, 2025   December 31, 2024 Revenue   $ 162.3     $ 182.5     $ 173.2   Gross Margin     21.5

    2/5/26 4:01:00 PM ET
    $AOSL
    Semiconductors
    Technology

    Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600

    NEW YORK, Feb. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600:  S&P MidCap 400 constituent Ciena Corp. (NYSE:CIEN) will replace Dayforce Inc. (NYSE:DAY) in the S&P 500, S&P SmallCap 600 constituent Arrowhead Pharmaceuticals Inc. (NASD: ARWR) will replace Ciena in the S&P MidCap 400, and ADT Inc. (NYSE:ADT) will replace Arrowhead Pharmaceuticals in the S&P SmallCap 600 effective prior to the opening of trading on Monday, February 9. Thoma Bravo L.P. acquired Dayforce in a deal that closed today.OneSpaWorld Holdings Ltd. (NASD: OSW) will replace Dynavax Technologies Corp. (NASD: DVAX) in the S&P SmallCap 600 effec

    2/4/26 6:15:00 PM ET
    $ADT
    $ARWR
    $CIEN
    Diversified Commercial Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AOSL
    $DVAX
    $EPAY
    $IRT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Independence Realty Trust downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded Independence Realty Trust from Buy to Hold and set a new price target of $18.00

    1/20/26 9:09:45 AM ET
    $IRT
    Real Estate Investment Trusts
    Real Estate

    Independence Realty Trust upgraded by BMO Capital Markets with a new price target

    BMO Capital Markets upgraded Independence Realty Trust from Market Perform to Outperform and set a new price target of $22.00

    1/9/26 8:29:37 AM ET
    $IRT
    Real Estate Investment Trusts
    Real Estate

    Independence Realty Trust downgraded by Colliers Securities with a new price target

    Colliers Securities downgraded Independence Realty Trust from Buy to Neutral and set a new price target of $18.50

    12/4/25 8:27:22 AM ET
    $IRT
    Real Estate Investment Trusts
    Real Estate

    $AOSL
    $DVAX
    $EPAY
    $IRT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Myers Scott Dunseth bought $41,116 worth of shares (3,800 units at $10.82), increasing direct ownership by 12% to 35,004 units (SEC Form 4)

    4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Issuer)

    8/25/25 8:50:44 AM ET
    $DVAX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AOSL
    $DVAX
    $EPAY
    $IRT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP-WW Sales & Bus Development Xue Bing sold $54,932 worth of Common Share (2,460 units at $22.33), decreasing direct ownership by 2% to 116,039 units (SEC Form 4)

    4 - ALPHA & OMEGA SEMICONDUCTOR Ltd (0001387467) (Issuer)

    2/18/26 4:01:52 PM ET
    $AOSL
    Semiconductors
    Technology

    SEC Form 4 filed by Large owner Deep Track Biotechnology Master Fund, Ltd.

    4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Issuer)

    2/11/26 4:30:23 PM ET
    $DVAX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Emini Emilio returned 10,075 units of Common Stock - Restricted Stock Units to the company, closing all direct ownership in the company (SEC Form 4)

    4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Issuer)

    2/10/26 4:15:20 PM ET
    $DVAX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AOSL
    $DVAX
    $EPAY
    $IRT
    SEC Filings

    View All

    SEC Form 15-12G filed by Dynavax Technologies Corporation

    15-12G - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)

    2/20/26 6:05:36 AM ET
    $DVAX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Independence Realty Trust Inc.

    10-K - INDEPENDENCE REALTY TRUST, INC. (0001466085) (Filer)

    2/17/26 4:31:11 PM ET
    $IRT
    Real Estate Investment Trusts
    Real Estate

    SEC Form 144 filed by Alpha and Omega Semiconductor Limited

    144 - ALPHA & OMEGA SEMICONDUCTOR Ltd (0001387467) (Subject)

    2/17/26 4:05:14 PM ET
    $AOSL
    Semiconductors
    Technology

    $AOSL
    $DVAX
    $EPAY
    $IRT
    Leadership Updates

    Live Leadership Updates

    View All

    Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600

    NEW YORK, Feb. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600:  S&P MidCap 400 constituent Ciena Corp. (NYSE:CIEN) will replace Dayforce Inc. (NYSE:DAY) in the S&P 500, S&P SmallCap 600 constituent Arrowhead Pharmaceuticals Inc. (NASD: ARWR) will replace Ciena in the S&P MidCap 400, and ADT Inc. (NYSE:ADT) will replace Arrowhead Pharmaceuticals in the S&P SmallCap 600 effective prior to the opening of trading on Monday, February 9. Thoma Bravo L.P. acquired Dayforce in a deal that closed today.OneSpaWorld Holdings Ltd. (NASD: OSW) will replace Dynavax Technologies Corp. (NASD: DVAX) in the S&P SmallCap 600 effec

    2/4/26 6:15:00 PM ET
    $ADT
    $ARWR
    $CIEN
    Diversified Commercial Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Deep Track Capital Comments on ISS Recommendation

    Strongly Disagrees with Recommendation and Believes ISS Ignored Key Issues in Its Incomplete Analysis ISS Has Chosen Not to Hold the Board Accountable for Its Underperformance in Recent Years, Heplisav's Waning Market Share Growth and Poor Corporate Governance Urges Shareholders to Vote FOR Deep Track's Four Highly Qualified Director Nominees Deep Track Capital, LP, (together with its affiliates, "Deep Track" or "we"), one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ:DVAX) ("Dynavax", "DVAX" or the "Company"), with ownership of approximately 14.82% of the Company's outstanding shares, today issued the following statement in response to a report issued by Instit

    5/23/25 6:12:00 PM ET
    $DVAX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

    ISS Recognizes There is No Case for Change Dynavax's Superior Strategy and Current Board are Best Equipped to Deliver Significant Long-Term Stockholder Value Dynavax Comments on Deep Track's Misleading Supplemental Materials Urges Stockholders to Follow ISS Recommendation and Vote "FOR" ALL Four of Dynavax's Highly Qualified Director Nominees on the GOLD Proxy Card Today EMERYVILLE, Calif., May 23, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (NASDAQ:DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that leading independent proxy advisory firm, Institutional Shareholder Services ("ISS

    5/23/25 1:44:00 PM ET
    $DVAX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AOSL
    $DVAX
    $EPAY
    $IRT
    Financials

    Live finance-specific insights

    View All

    Alpha and Omega Semiconductor Reports Financial Results for the Fiscal Second Quarter of 2026 Ended December 31, 2025

    Alpha and Omega Semiconductor Limited ("AOS") (NASDAQ:AOSL) today reported financial results for the fiscal second quarter of 2026 ended December 31, 2025. The results for the fiscal second quarter of 2026 ended December 31, 2025 were as follows: GAAP Financial Comparison Quarterly (in millions, except percentage and per share data) (unaudited)     Three Months Ended     December 31, 2025   September 30, 2025   December 31, 2024 Revenue   $ 162.3     $ 182.5     $ 173.2   Gross Margin     21.5

    2/5/26 4:01:00 PM ET
    $AOSL
    Semiconductors
    Technology

    Independence Realty Trust Announces Tax Treatment of Dividends in 2025

    Independence Realty Trust, Inc. ("IRT") (NYSE:IRT) today announced the tax status of 2025 dividend distributions on its common stock. The final income allocations as they will be reported on Form 1099-DIV are set forth in the following table: Common Shares (CUSIP #45378A106) Record Date Payment Date Distribution Per Share Ordinary Dividend Total Capital Gain Distr. Unrecap- tured Sec. 1250 Gain Section 897 Capital Gain Return of Capital Section 199A 3/28/25 4/21/25 $0.16000 $0.09299 $0.06701 $0.02570 $0.06701 $0.00000 $0.09299 6/27/25 7/18/25 $0.17000 $

    1/23/26 4:05:00 PM ET
    $IRT
    Real Estate Investment Trusts
    Real Estate

    IRT Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    Independence Realty Trust, Inc. ("IRT") (NYSE:IRT), announces the release date and conference call details in which management will discuss fourth quarter and full year 2025 financial results. Details: Results Release Date: Wednesday, February 11, 2026, after the market closes   Conference Call Date and Time: Thursday, February 12, 2026, at 9:00 a.m. Eastern Time   Telephone Number (within the U.S.): (888) 440-3307   Conference ID (Passcode): 1963990 The live conference call can also be accessed from the ‘Investors' section of the IRT website, https://investors.irtliving.com. Replay Information:

    1/20/26 8:00:00 AM ET
    $IRT
    Real Estate Investment Trusts
    Real Estate

    $AOSL
    $DVAX
    $EPAY
    $IRT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Independence Realty Trust Inc.

    SC 13G - INDEPENDENCE REALTY TRUST, INC. (0001466085) (Subject)

    11/14/24 1:28:32 PM ET
    $IRT
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G filed by Dynavax Technologies Corporation

    SC 13G - DYNAVAX TECHNOLOGIES CORP (0001029142) (Subject)

    11/14/24 12:18:08 PM ET
    $DVAX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Independence Realty Trust Inc.

    SC 13G - INDEPENDENCE REALTY TRUST, INC. (0001466085) (Subject)

    11/8/24 10:34:33 AM ET
    $IRT
    Real Estate Investment Trusts
    Real Estate